Ebola Outbreak Spurs Drug, Vaccine Development; Dozen Companies Have Products In Pipeline
Executive Summary
NewLink Genetics speeds development of its Ebola vaccine at government’s urging, Tekmira gets FDA clearance to provide its Phase I compound, and Mapp Biopharmaceutical is moving to ramp up production of its preclinical drug following administration to two American health care workers.